| Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ... Genetics in Medicine 19 (2), 215-223, 2017 | 492 | 2017 |
| Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers HM Dunnenberger, KR Crews, JM Hoffman, KE Caudle, U Broeckel, ... Annual review of pharmacology and toxicology 55 (1), 89-106, 2015 | 474 | 2015 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209, 2014 | 446 | 2014 |
| The second victim experience and support tool: validation of an organizational resource for assessing second victim effects and the quality of support resources JD Burlison, SD Scott, EK Browne, SG Thompson, JM Hoffman Journal of patient safety 13 (2), 93-102, 2017 | 270 | 2017 |
| PG4KDS: a model for the clinical implementation of pre‐emptive pharmacogenetics JM Hoffman, CE Haidar, MR Wilkinson, KR Crews, DK Baker, ... American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014 | 267 | 2014 |
| The clinical pharmacogenetics implementation consortium: 10 years later MV Relling, TE Klein, RS Gammal, M Whirl‐Carrillo, JM Hoffman, ... Clinical Pharmacology & Therapeutics 107 (1), 171-175, 2020 | 254 | 2020 |
| Development and use of active clinical decision support for preemptive pharmacogenomics GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ... Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014 | 237 | 2014 |
| Economic evaluations of clinical pharmacy services: 2001–2005 F Doloresco, JM Hoffman, PD Meek Pharmacotherapy 28 (11), 285e-323e, 2008 | 225 | 2008 |
| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 219 | 2022 |
| NCCN biosimilars white paper: regulatory, scientific, and patient safety perspectives AD Zelenetz, I Ahmed, EL Braud, JD Cross, N Davenport-Ennis, ... Journal of the National Comprehensive Cancer Network 9 (Suppl_4), S-1-S-22, 2011 | 198 | 2011 |
| Patient safety culture and the second victim phenomenon: connecting culture to staff distress in nurses RR Quillivan, JD Burlison, EK Browne, SD Scott, JM Hoffman The Joint Commission Journal on Quality and Patient Safety 42 (8), 377-AP2, 2016 | 191 | 2016 |
| Economic evaluations of clinical pharmacy services: 2006–2010 DR Touchette, F Doloresco, KJ Suda, A Perez, S Turner, Y Jalundhwala, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (8 …, 2014 | 178 | 2014 |
| Development and implementation of a pharmacist-managed clinical pharmacogenetics service KR Crews, SJ Cross, JN McCormick, DK Baker, AR Molinelli, R Mullins, ... American Journal of Health-System Pharmacy 68 (2), 143-150, 2011 | 170 | 2011 |
| The effects of the second victim phenomenon on work-related outcomes: connecting self-reported caregiver distress to turnover intentions and absenteeism JD Burlison, RR Quillivan, SD Scott, S Johnson, JM Hoffman Journal of Patient Safety 17 (3), 195-199, 2021 | 167 | 2021 |
| Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza AH Gaur, B Bagga, S Barman, R Hayden, A Lamptey, JM Hoffman, ... New England journal of medicine 362 (1), 88-89, 2010 | 165 | 2010 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing: 2014 Update MA Martin, JM Hoffman, RR Freimuth, TE Klein, BJ Dong, M Pirmohamed, ... Clinical Pharmacology & Therapeutics 95 (5), 499-500, 2014 | 158 | 2014 |
| Medication errors caused by confusion of drug names JM Hoffman, SM Proulx Drug safety 26, 445-452, 2003 | 153 | 2003 |
| Integrating pharmacogenomics into electronic health records with clinical decision support JK Hicks, HM Dunnenberger, KF Gumpper, CE Haidar, JM Hoffman American journal of health-system pharmacy 73 (23), 1967-1976, 2016 | 143 | 2016 |
| National survey on the effect of oncology drug shortages on cancer care A McBride, LM Holle, C Westendorf, M Sidebottom, N Griffith, RJ Muller, ... American journal of health-system pharmacy 70 (7), 609-617, 2013 | 138 | 2013 |
| ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics. CE Haidar, JM Hoffman, SG Johnson, MV Relling, KR Crews American Journal of Health-System Pharmacy 72 (7), 2015 | 133* | 2015 |
Mary V. RellingSt. Jude Children's Research HospitalOverená e-mailová adresa na: stjude.org
